Allied Medical

MO - St. LouisMedical Devices1 H-1B visas (FY2023)

Focus: Allied Medical is a medical device and specialty pharmaceutical company headquartered in St. Louis, MO, focused on infectious diseases, cardiovascular, neurology, hematology, and vaccine therapeutics.

Infectious Diseases Cardiovascular Neurology Hematology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Allied Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Allied Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

FLUOCINOLONE ACETONIDE

Not specified

Pre-Launch

ANDA formulation in pre-launch phase; corticosteroid positioned for dermatological or inflammatory indications.

Help build intelligence for Allied Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline spans high-impact infectious disease programs including Phase 3 azithromycin for diarrhea and Phase 2 HIV and TB vaccine candidates, offering exposure to global health challenges
Diverse therapeutic portfolio across 5 disease areas (Infectious Diseases, Cardiovascular, Neurology, Hematology, Vaccines) provides broad clinical development experience
H1B sponsorship track record (1 approval, 0 denials in 2023) signals openness to international talent recruitment

Watch Out For

Zero active job openings at the time of this data snapshot indicates potential hiring freeze or organizational contraction
Limited public financial data, employee count, and funding information makes it difficult to assess company stability, growth trajectory, or compensation competitiveness

Generated by Claude from Allied Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Post-loss-of-exclusivity generic indicating mature market position with limited growth potential.

Pipeline & Clinical Trials

Porridge protein calorie supplement

Low Birth Weight

N/A

Venipuncture for blood draw

Chikungunya

N/A

Clinical Trials (1)

NCT02463968Chikungunya Arthritis in the Americas

N/A

Speech rehabilitation

Stroke Rehabilitation

N/A

praziquantel and albendazole

Intestinal Schistosomiasis

N/A

Clinical Trials (1)

NCT01541631A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes

N/A

Human Milk Fortifier

Very Preterm Infant

N/A

Clinical Trials (1)

NCT06765863LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk

N/A

dihydroartemisinin-piperaquine

Malaria

N/A

Clinical Trials (1)

NCT05874869Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania

N/A

HBSAg

Hepatitis B

N/A

Behavioral and managerial

Low Back Pain

N/A

Clinical Trials (1)

NCT00962169Guideline Implementation in Physiotherapy

N/A

Enhanced Usual Care Group

Hypertension

N/A

Clinical Trials (1)

NCT06985199Culturally-adapted Mobile Health Intervention for Hypertension Care

N/A

Low-birthweight Infant Feeding Exploration

Low Birthweight

N/A

Clinical Trials (1)

NCT04002908Low-birthweight Infant Feeding Exploration

N/A

Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium

Hypertension

N/A

Clinical Trials (1)

NCT00324883Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium

N/A

Blood glucose and blood pressure testing

Human Immunodeficiency Virus

N/A

Clinical Trials (1)

NCT03098654Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania

N/A

Hypofractionated radiotherapy for low- and intermediate-risk prostate cancer patients

Prostate Cancer

N/A

Clinical Trials (1)

NCT06950307Hypofractionation for Prostate Cancer in Africa: A Feasibility Study

N/A

Diagnosis of

Neurocysticercosis

N/A

Clinical Trials (1)

NCT03851419The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania

N/A

Lung ultrasound

Pneumonia

N/A

Clinical Trials (1)

NCT06670833Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAP

N/A

Facility-based feeding support package plus

Low Birthweight

N/A

DAR-901

Tuberculosis

Phase 2

Clinical Trials (1)

NCT02712424DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

Phase 2

Maytenus Senegalensis

Malaria

Phase 2

Clinical Trials (1)

NCT04944966Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria

Phase 2

Comprehensive Triaged HIV Prevention

HIV

Phase 2

Clinical Trials (1)

NCT02018978Comprehensive Triaged HIV Prevention in Tanzania

Phase 2

Vaccine Group A: DNA-HIV-PT123 and AIDSVAX® B/E

HIV Infections

Phase 2

HIVIS DNA vaccine

HIV

Phase 2

Clinical Trials (1)

NCT01697007A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique

Phase 2

Appreciative Inquiry Change Agents

HIV Infection

Phase 3

Clinical Trials (1)

NCT01693458Positive Change Agents Program-Tanzania (Evaluation)

Phase 3

azithromycin

Diarrhea

Phase 3

Clinical Trials (1)

NCT03130114Antibiotics for Children With Severe Diarrhoea